Shanghai Labway Clinical Laboratory Co., Ltd (SZSE: 301060)
Health Care · Health Care Providers & Services · CN
CN¥11.50
-8.44% today · +8.6% 1Y
Shanghai Labway Clinical Laboratory Co., Ltd (SZSE: 301060) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $681.75M and employs 1,245 people.
Over the last twelve months the share price has gained 8.6%, trading between 7.86 and 14.55.
Tweenvest scores Shanghai Labway Clinical Laboratory Co., Ltd across four factors: quality 72/100, value 44/100, growth 55/100, dividend 44/100. Its strongest factor is quality.
301060 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $681.75M
- Revenue (TTM)
- $188.48M
- P/E
- 87.49
- EPS
- 0.13
- Dividend yield
- 1.57%
- Beta (5Y)
- 0.50
- 52-week high
- CN¥14.55
- 52-week low
- CN¥7.86
- Avg volume (3M)
- —
- Shares outstanding
- 398.52M
- Employees
- 1,245
- Next earnings
- —
About Shanghai Labway Clinical Laboratory Co., Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. provides a dual service offering: comprehensive medical laboratory services and the distribution of in vitro diagnostic (IVD) products. Established in 1993, the company is headquartered in Shanghai, China.
- Founded
- 1993
- Listed since
- Sep 13, 2021
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.